Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lourdes Florensa

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Cancers|August 26, 2023
Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at DiagnosisSara Montesdeoca, Nieves García-Gisbert, Xavier Calvo, et al.
British Journal of Haematology|September 11, 2012
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromesSílvia Saumell, Lourdes Florensa, Elisa Luño, et al.
American Journal of Hematology|June 15, 2017
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS groupFernando Ramos, Cristina Robledo, Arturo Pereira, et al.
Annals of Hematology|May 15, 2014
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1María Rozman, José-Tomás Navarro, Leonor Arenillas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic SyndromesLeonor Arenillas, Xavier Calvo, Elisa Luño, et al.
British Journal of Haematology|April 26, 2013
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutationsMar Mallo, Mónica Del Rey, Mariam Ibáñez, et al.
Genes, Chromosomes & Cancer|October 15, 2013
Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testingLeonor Arenillas, Mar Mallo, Fernando Ramos, et al.
Plos One|June 13, 2015
Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?Sílvia Saumell, Francesc Solé, Leonor Arenillas, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2015
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3Jose Maria Raya, Taida Martín-Santos, Elisa Luño, et al.
Medicina Clinica|March 15, 2011
[Persistent polyclonal B-cell lymphocytosis: study of 35 cases]Lourdes Florensa, José Tomás Navarro, María Encarnación Pérez Vila, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cancers|August 26, 2023
Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at DiagnosisSara Montesdeoca, Nieves García-Gisbert, Xavier Calvo, et al.
British Journal of Haematology|September 11, 2012
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromesSílvia Saumell, Lourdes Florensa, Elisa Luño, et al.
American Journal of Hematology|June 15, 2017
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS groupFernando Ramos, Cristina Robledo, Arturo Pereira, et al.
Annals of Hematology|May 15, 2014
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1María Rozman, José-Tomás Navarro, Leonor Arenillas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic SyndromesLeonor Arenillas, Xavier Calvo, Elisa Luño, et al.
British Journal of Haematology|April 26, 2013
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutationsMar Mallo, Mónica Del Rey, Mariam Ibáñez, et al.
Genes, Chromosomes & Cancer|October 15, 2013
Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testingLeonor Arenillas, Mar Mallo, Fernando Ramos, et al.
Plos One|June 13, 2015
Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?Sílvia Saumell, Francesc Solé, Leonor Arenillas, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2015
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3Jose Maria Raya, Taida Martín-Santos, Elisa Luño, et al.
Medicina Clinica|March 15, 2011
[Persistent polyclonal B-cell lymphocytosis: study of 35 cases]Lourdes Florensa, José Tomás Navarro, María Encarnación Pérez Vila, et al.
Pageof 6